Austrian Wearable Cardioverter Defibrillator Registry

Heart Failure Clinical Trial

Official title: Indications for and Experience With the Wearable Cardioverter Defibrillator (WCD) - Austrian WCD Registry

Status Recruiting

Clinical Trial Summary

Background: The wearable cardioverter defibrillator (WCD) is an established treatment option for patients at high risk for ventricular tachycardia / ventricular fibrillation (VT/VF), either in whom this risk may only be temporarily present, or in patients at high risk for sudden cardiac death (SCD) or after VT/VF in whom an implantable cardioverter defibrillator (ICD is currently not possible for other reasons (infection, recent MI <40days, recent PCI/CABG < 3months etc.).

Methods: Comprehensive registry including all patients in Austria who received a WCD in 2010-2016.

Clinical Trial Description

Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients ;

Related Conditions & MeSH terms

• Death, Sudden
• Death, Sudden, Cardiac
• Heart Failure
• Sudden Cardiac Arrest
• Sudden Death
• Tachycardia
• Tachycardia, Ventricular
• Ventricular Dysfunction
• Ventricular Fibrillation
• Ventricular Tachycardia

• NCT number: NCT02816047
• Study type: Observational
• Source: Medical University of Graz
• Contact: Daniel Scherr, Assoz. Prof.
• Phone: 004331638512544
• Email: daniel.scherr@medunigraz.at
• Status: Recruiting
• Start date: November 2014
• Completion date: March 2022